Oscar Health (OSCR) Stock Price, News & Analysis

$17.56
-0.33 (-1.84%)
(As of 04/26/2024 ET)
Today's Range
$17.52
$18.20
50-Day Range
$13.50
$17.89
52-Week Range
$4.72
$18.55
Volume
2.62 million shs
Average Volume
3.20 million shs
Market Capitalization
$4.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.50

Oscar Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
23.1% Downside
$13.50 Price Target
Short Interest
Bearish
5.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.23) to $0.42 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.82 out of 5 stars

Finance Sector

805th out of 864 stocks

Hospital & Medical Service Plans Industry

10th out of 10 stocks

OSCR stock logo

About Oscar Health Stock (NYSE:OSCR)

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

OSCR Stock Price History

OSCR Stock News Headlines

Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Oscar Health, Inc. (OSCR)
Oscar Health, Inc. to Host 2024 Investor Day
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
OSCR Apr 2024 16.000 call
OSCR Apr 2024 10.000 put
OSCR Apr 2024 22.500 call
Oscars 2024: All the winners from the Academy Awards
Oscar Health (OSCR) Appreciated 270% in 2023
OSCR Dec 2025 10.000 call
OSCR Mar 2024 25.000 call
OSCR Dec 2024 7.500 call
Oscar Health Inc (OSCR)
OSCR Oct 2024 7.500 call
OSCR Aug 2024 10.000 put
OSCR Oct 2024 5.000 put
See More Headlines
Receive OSCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oscar Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Today
4/26/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Hospital & medical service plans
Sub-Industry
N/A
Fax
N/A
Employees
2,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.50
High Stock Price Target
$20.00
Low Stock Price Target
$7.50
Potential Upside/Downside
-23.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-270,730,000.00
Pretax Margin
-4.56%

Debt

Sales & Book Value

Annual Sales
$5.86 billion
Book Value
$3.51 per share

Miscellaneous

Free Float
171,055,000
Market Cap
$4.03 billion
Optionable
Optionable
Beta
1.79
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

OSCR Stock Analysis - Frequently Asked Questions

Should I buy or sell Oscar Health stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OSCR shares.
View OSCR analyst ratings
or view top-rated stocks.

What is Oscar Health's stock price target for 2024?

6 Wall Street analysts have issued twelve-month price targets for Oscar Health's shares. Their OSCR share price targets range from $7.50 to $20.00. On average, they anticipate the company's share price to reach $13.50 in the next twelve months. This suggests that the stock has a possible downside of 23.1%.
View analysts price targets for OSCR
or view top-rated stocks among Wall Street analysts.

How have OSCR shares performed in 2024?

Oscar Health's stock was trading at $9.15 at the start of the year. Since then, OSCR shares have increased by 91.9% and is now trading at $17.56.
View the best growth stocks for 2024 here
.

When is Oscar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our OSCR earnings forecast
.

How can I listen to Oscar Health's earnings call?

Oscar Health will be holding an earnings conference call on Tuesday, May 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Oscar Health's earnings last quarter?

Oscar Health, Inc. (NYSE:OSCR) issued its quarterly earnings results on Wednesday, February, 7th. The company reported ($0.66) earnings per share for the quarter, topping analysts' consensus estimates of ($0.74) by $0.08. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. Oscar Health had a negative trailing twelve-month return on equity of 29.99% and a negative net margin of 4.62%. The company's revenue for the quarter was up 43.9% on a year-over-year basis. During the same period in the previous year, the company earned ($1.05) earnings per share.

What guidance has Oscar Health issued on next quarter's earnings?

Oscar Health updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $8.3 billion-$8.4 billion, compared to the consensus revenue estimate of $6.8 billion.

What is Mario T. Schlosser's approval rating as Oscar Health's CEO?

207 employees have rated Oscar Health Chief Executive Officer Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among the company's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

When did Oscar Health IPO?

Oscar Health (OSCR) raised $1 billion in an initial public offering on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at a price of $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse served as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Who are Oscar Health's major shareholders?

Oscar Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.67%), Allspring Global Investments Holdings LLC (0.12%), Gunderson Capital Management Inc. (0.11%), Simplex Trading LLC (0.00%), IMC Chicago LLC (0.00%) and Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Alessandrea C Quane, Alphabet Inc, Dennis Weaver, Joshua Kushner, Mario Schlosser, Meghan V Joyce, Ranmali Bopitiya, Richard Scott Blackley, Sid Sankaran, Thrive Partners Vii Growth Gp, and Victoria Baltrus.
View institutional ownership trends
.

How do I buy shares of Oscar Health?

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:OSCR) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners